MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,666 | -16.4% | 54,210 | +19.6% | 0.00% | – |
| Q2 2023 | $310,552 | +23.7% | 45,336 | +40.7% | 0.00% | – |
| Q1 2023 | $251,095 | -24.9% | 32,233 | -26.7% | 0.00% | – |
| Q4 2022 | $334,551 | +23.0% | 43,962 | +32.0% | 0.00% | – |
| Q3 2022 | $272,000 | -29.9% | 33,294 | -17.0% | 0.00% | – |
| Q2 2022 | $388,000 | -44.4% | 40,116 | -19.5% | 0.00% | – |
| Q1 2022 | $698,000 | -1.7% | 49,817 | +43.4% | 0.00% | – |
| Q4 2021 | $710,000 | +66.7% | 34,746 | +81.7% | 0.00% | – |
| Q3 2021 | $426,000 | -82.7% | 19,119 | -82.4% | 0.00% | -100.0% |
| Q2 2021 | $2,463,000 | – | 108,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |